QBKPN-SSI

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameQBKPN-SSI
Drug Alias NameLung targeted site specific immunomodulator - Qu Biologics
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulantsNatural killer cells stimulants
TargetsNot applicable
Therapy Area/IndicationsImmunologic Deficiency SyndromesCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesQu Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesQu Biologics Inc
Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency Syndromes
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A